An interventional study of low intensity laser therapy ,muscle training using incentive spirometer associated with postural drainage in addition to medical treatment. Measurements and received inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment. in Pneumonia, sponsored by Badr University. Recruiting at 1 site in Egypt. Open to participants aged 3 Years to 5 Years. Per ClinicalTrials.gov, last updated 2026-04-27.
Sponsored by Badr University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 39 studies in Pneumonia with a site in Egypt — 9 open to participants now, 11 under way, 1 of them phase 3. Pneumonia · Egypt.
Among the 39 studies in Pneumonia with a site in Egypt, this one is the 23rd largest by planned enrollment of the 26 interventional ones that give a count, is one of 3 that started in 2026, is one of 20 with no phase, reaches primary completion later than 6 of the 10 other live ones, and was the 38th registered.
1,569 studies on the registry are indexed under Pneumonia; 267 are open to participants now.
Browse Pneumonia studies →9 of the 39 studies in Pneumonia with a site in Egypt are open now. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 18–64
Badr University · Sites in Egypt
Ages 1–6
Assiut University · Sites in Egypt
Ages 18+ · Healthy volunteers
Cairo University · Sites in Egypt
Ages 49–65
Cairo University · Sites in Egypt
Ages 40–50
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 159 Pneumonia studies recruiting now, 84 (53%) set no upper age limit and 48 (30%) stop at 75 or younger; 40 take children under 18; 23 take healthy volunteers.
This study: 3 Years to 5 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
39 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2 · Phase 3 2 · Phase 4 3
First in 2019; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 128 across 978 interventional studies indexed under Pneumonia.
Median enrollment 70 across the 26 interventional studies, 70 across the 13 observational. Of the 20 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 39 has an industry lead sponsor. The 10 most frequent:
Badr University is the lead sponsor of 64 studies on the registry; 18 are open to participants now.
Badr University has 2 studies filed under Pneumonia — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 39 studies in Pneumonia with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Objective: The aim of this study was to detect the impact of low intensity laser therapy on immune system response among DS children with pneumonia. Material and Methods: Forty DS children with bronchopneumonia, were included into ; group (A) received low intensity laser therapy, inspiratory muscle training in addition to medical treatment at a frequency of 3 sessions per week for one month, where the second group (B) received inspiratory muscle training in addition to medical treatment. Measurements of WBCs, IgG, IgA, IgM, RR and SaO2 were obtained for both groups before treatment and after one month at the end of the treatment program.
The aim of this study was to detect the impact of low intensity laser therapy on immune system response among DS children with pneumonia. Material and Methods: Forty DS children with bronchopneumonia, mean age of 3.73±1.82 year and were included into 2 equal groups; group (A) received low intensity laser therapy, inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment at a frequency of 3 sessions per week for one month, where the second group (B) received inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment. Measurements of WBCs, IgG, IgA, IgM, RR and SaO2 were obtained for both groups before treatment and after one month at the end of the treatment program.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
received low intensity laser therapy, inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment at a frequency of 3 sessions per week for one month
Other: low intensity laser therapy ,muscle training using incentive spirometer associated with postural drainage in addition to medical treatment. Measurements · Other: received inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment.
received inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment.
Other: received inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment.
low intensity laser therapy ,muscle training using incentive spirometer associated with postural drainage in addition to medical treatment. Measurements
Also known as: low intensity laser therapy, muscle training using incentive spirometer associated with postural drainage in addition to medical treatment. Measurements
received inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment.
Also known as: inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment.
IgG
Immunoglobulin-G (mg/dl)
Time frame: at baseline and after one month
IgA
Immunoglobulin-A(mg/dl)
Time frame: at baseline and after one month
IgM
Immunoglobulin-M (mg/dl)
Time frame: at baseline and after one month
WBCs
White blood cells (thousands/mm3)
Time frame: at baseline and after one month
RR
Respiratory Rate(breath/minute)
Time frame: at baseline and after one month
SaO2
Arterial oxygen saturation(%)
Time frame: at baseline and after one month
Started Apr 2026 (actual). Primary completion is estimated for May 2026, 1 month after the start.
Of 260 non-industry interventional studies with no phase under Pneumonia, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 31. This study's planned 1 month is below that.
Counting every sponsor, half of 267 studies reached it within 22 months; a quarter within 11 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Badr University